FDA Inspection
Edge Pharma, LLCEdge Pharma, LLC – FDA Inspection, Mar 8, 2018
Record Details
This FDA Inspection record concerns Edge Pharma, LLC, with an inspection on March 8, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 4d7f95a2-7394-47d5-b1a8-7901ab1976b8
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1043506
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
15- 21 CFR 211.22(b)Adequate lab facilities not available
- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.84(d)(2)Establish reliability of supplier"s C of A
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.186(a)Written procedures followed
Showing 10 of 15 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Edge Pharma, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 30, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 20, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Edge Pharma, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.